Decapentaplegic/DPP Antibody (146609) [mFluor Violet 500 SE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB159MFV500

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Asp457-Arg588 (Gln473His, Pro474Ala)
Accession # NP_722813.1
Specificity
Clonality
Host
Isotype
Applications for Decapentaplegic/DPP Antibody (146609) [mFluor Violet 500 SE]
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: Decapentaplegic/DPP
Decapentaplegic (Dpp) is one of at least five TGF-beta superfamily ligands identified in the Drosophila genome. Dpp, a functional orthologue of mammalian BMP-2 and BMP-4, is a morphogen and plays an essential role in Drosophila development. Dpp regulates embryonic dorsal-ventral polarity and is required for gut morphogenesis and outgrowth and patterning of imaginal disks. Cellular responses to Dpp are mediated by the ligand-induced formation of heteromeric complexes of the Drosophila type I, Thick Veins (Tkv), and type II, Punt, serine/threonine kinases. The activated receptor complex induces the phosphorylation of the prototypical Smad, Mad, and subsequent translocation of the Mad-Medea complex to the nucleus where they regulate the transcription of target genes. Secreted extracellular Dpp antagonists, including the short-gastrulation (Sog) and twisted gastrulation (TSG), bind to Dpp and regulate its availability.
Alternate Names
Additional Decapentaplegic/DPP Products
Product Documents for Decapentaplegic/DPP Antibody (146609) [mFluor Violet 500 SE]
Product Specific Notices for Decapentaplegic/DPP Antibody (146609) [mFluor Violet 500 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.